Attis Industries Launches Video Series Demonstrating the Benefit of PGx Testing for Employers

MILTON, GA, Jan. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Attis Industries Inc. (NASDAQ: ATIS) (the “Company” or “Attis”), a diversified innovation and technology holding company focused on renewable fuels, bio-based plastics, healthcare and a high-tech communications infrastructure, today released a video aimed to educate self-funded employers on how offering PGx (Pharmacogenetic) testing and medication risk management for employees can help reduce spiraling healthcare costs. 

Link to video:

“Healthcare coverage is the largest employee-related expense for U.S. employers and pharmacy spend, in particular, is out of control and growing. We know companies are trying to reduce their healthcare spend, and more importantly, maintain healthy and more productive employees,” said Rob Dunn, President of Attis Healthcare. As a distributor, Attis Healthcare works alongside the employer to ensure test results are interpreted and help guide the employee/employer toward an actionable plan they can discuss with their healthcare provider.

“Pharmacogenetic testing is not new in the employer space. However, in the past, the results were overwhelming and employees did not know how to understand results and implement changes,” Dunn added. “We now offer medication management tools and consultants that empower both employers and employees to bring about real change.”

Attis’ video was created to complement a series launched by the Company’s Innovations Division, which was designed to offer investors, future clients and interested parties additional information on the unique technologies and bio-based products available.  More videos are scheduled to launch in the coming months as part of our commitment to educating key audiences while creating shareholder value and operational transparency.

Attis Industries, Inc.
Attis Industries Inc. (NASDAQ: ATIS) is a holding company focused on developing and building businesses that play important roles in the new economy. We strive to encourage our employees to be entrepreneurs focused on innovation and technology. We will remain dynamic, persistent and motivated to our mission of winning. The growth of our company will rely on our integrity and our vision for the future. Attis Industries will continue to fulfill essential needs in healthcare, energy independence and digital communications. Today, each of these sectors provide high growth opportunities that collectively account for more than a third of our nations GDP. For more information, visit:

Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “should,” “would” or similar words. You should consider these statements carefully because they discuss our plans, targets, strategies, prospects and expectations concerning our business, operating results, financial condition and other similar matters. These statements are subject to certain risks, uncertainties, and assumptions, including, but not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and, the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies; the ability of the Company to continue to meet the listing requirements of NASDAQ; the ability of the Company to execute on a business plan that permits the technologies and innovations businesses to provide sufficient growth, revenue, liquidity and cash flows for sustaining the Company’s go-forward business, and the risks identified and discussed under the caption “Risk Factors” in the Attis Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed with the Securities and Exchange Commission (the “SEC”) on April 16, 2018 and the other documents Attis files with the SEC from time to time. There will be events in the future, however, that Attis is not able to predict accurately or control. Attis’s actual results may differ materially from the expectations that Attis describes in its forward-looking statements. Factors or events that could cause Attis’s actual results to materially differ may emerge from time to time, and it is not possible for Attis to accurately predict all of them. Any forward-looking statement made by Attis in this press release speaks only as of the date on which Attis makes it. Attis undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.


Contact Data